Product Reports Resources Pricing Login Book a demo

Thermo Fisher Scientific

Biotech & Life Sciences · Waltham, United States · Founded 1956 · IPO 2014

Scientific instruments, diagnostics, and life sciences services. MoreLess

If you work in a lab, a hospital, or a biotech company, you probably can't get through your day without using a product from Thermo Fisher Scientific. They are the Amazon of the science world, a massive company that provides everything from basic lab supplies to complex analytical instruments and outsourced drug development services. But this giant wasn't built overnight; it's the result of a blockbuster merger between two very different, yet complementary, companies. The story starts on two separate tracks. First, there's Fisher Scientific, founded in 1902 by a 20-year-old engineering graduate from Pittsburgh, Chester G. Fisher. He saw a need to supply the labs of burgeoning industries like steel and created a one-stop shop for scientific tools. Fisher essentially became the definitive catalog and distributor for labs across North America. Decades later, in 1956, Greek immigrant and MIT PhD George Hatsopoulos co-founded Thermo Electron with Peter Nomikos. While Fisher was about distribution, Thermo Electron was about invention. Hatsopoulos was a brilliant engineer focused on applying thermodynamics to create new instruments and technologies. For 50 years, both companies grew independently. Fisher expanded its distribution network, went public in 1965, and became a staple in labs everywhere. Thermo Electron, driven by Hatsopoulos's innovative spirit, developed cutting-edge analytical instruments. The defining moment came in 2006, when the two companies announced a massive $10.6 billion merger. The deal combined Thermo's high-tech instruments with Fisher's vast distribution channels, creating the powerhouse we know today as Thermo Fisher Scientific. Since the merger, the company has been on an acquisition spree, buying dozens of companies to expand its reach into genomics, specialty diagnostics, and biopharma services, including major acquisitions like Life Technologies in 2013 and PPD in 2021. Today, Thermo Fisher Scientific is a dominant force in serving science, a nearly essential partner in global research and healthcare.

Valuation $272B
Revenue $48B
EBITDA $12B
Total funding $10–50M

Company overview

Thermo Fisher Scientific company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
1956
Headquarters
Waltham, United States
Employees
71,179
Open positions
7,082
Dealroom signal
64.3
Investment activity
60 companies · latest Oct 2025
Capital deployed
$285M
Preferred round
ACQUISITION
client focusb2btechnologyDeep TechtechnologyNanotechsub industryBioTechnologybusiness modelManufacturingsectorTestingindustryHealthsectorBiotechnologysectorOncologysectorDNAsectorGenetics and genomicssectorMedical Data SystemssectorGenome EngineeringsectorInnovation Radar

Valuation & funding

Thermo Fisher Scientific funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO DEBTDebt Feb 2026 $3.8B Undisclosed
POST IPO DEBTDebt Nov 2023 $2.5B Undisclosed
POST IPO DEBTDebt Aug 2023 $3B Undisclosed
GRANTOther financing Mar 2023 $500K National Grid
POST IPO DEBTDebt Nov 2021 $5.7B Undisclosed
POST IPO EQUITYOther financing Jan 2019 Phc
IPOExit Apr 2014 Undisclosed
SERIES BEquity / VC Mar 2007 GF Private Equity Group · Fuse Capital · Southern Ute · IPV Capital
Showing 8 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMarginProfitMarginR&D
2026 $48B +7.4% $12B 26.1% $7.4B 15.5% $1.4B
2025 $45B +3.9% $12B 26.6% $6.7B 15% $1.4B
2024 $43B +0.1% $12B 27.7% $6.3B 14.8% $1.4B
2023 $43B -4.6% $12B 26.9% $1.3B
2022 $45B +14.5% $12B 26.8%
2021 $39B +21.7% $12B 31%
2020 $32B $10B 31.7%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Thermo Fisher Scientific website traffic

Latest recorded traffic for Thermo Fisher Scientific is 7.4M monthly website visits, up 51% over the last three months. Thermo Fisher Scientific's team grew 0% over the past year.

Latest monthly visits7.4M 3-month web change+51% 1-year team growth0%
Monthly website visits41 observations · Apr 2016–Mar 2021
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Thermo Fisher Scientific compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Capital deployed

Thermo Fisher Scientific investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

ClarioLondon, United KingdomProvides advanced endpoint technology and data solutions to optimize and manage clinical trials for pharmaceutical, biotech, and medical device companies miDiagnosticsLeuven, BelgiumSilicon chip diagnostics for rapid, lab-quality results $132Mvaluation CytoreasonTel Aviv-Yafo, IsraelTurns human clinical data into clear biology, to deliver data-driven target discovery and drug development $320Mvaluation Olink ProteomicsUppsala kommun, SwedenDevelops ground-breaking technologies for biomolecular analysis $3.2Bvaluation CorEvitasWaltham, United StatesCorrona | Syndicated BioPharma Registry Data and Consulting Services $913Mvaluation MarqMetrixSeattle, United StatesYour business an affordable superpower $4Mvaluation The Binding Site GroupBirmingham, United KingdomDevelops, manufactures and distributes specialised immunodiagnostic assays and instrumentation to improve diagnosis and monitoring of blood cancers and immune-system disorders worldwide $2.6Bvaluation IonpathMenlo Park, United StatesEnabling precision medicine through high-definition spatial proteomics $72Mvaluation PharmaFluidicsGhent, BelgiumMicro-chip based columns for analytical liquid chromatography $32Mvaluation CombinatiPalo Alto, United StatesCombinati is a biotechnology company based in Palo Alto $23Mvaluation PPDWilmington, United StatesContract Research Organization (CRO) Clinical Trial Solutions with PPD $17Bvaluation WuXi DiagnosticsPudong, ChinaIntegrated diagnostics platform for multidisciplinary clinical data analysis $600Mvaluation

Talent graph

Thermo Fisher Scientific's talent

Book a demo to see the people
Team profiled 336 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Thermo Fisher Scientific's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
National Grid
Series A 6 investors entered at this stage
GF Private Equity Group
Fuse Capital
Southern Ute
IPV Capital
Castile Ventures
ARCH Venture Partners
Series B+ 1 investor entered at this stage
Phc

Global footprint

Where Thermo Fisher Scientific has talent and traffic

Workforce by country
🇺🇸 United States · Waltham HQ
Book a demo for the full country breakdown

In the news

Latest news about Thermo Fisher Scientific

Recent press, funding announcements, and product moves mentioning Thermo Fisher Scientific — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Thermo Fisher Scientific

An AI-synthesized read of the highest-engagement posts about Thermo Fisher Scientific on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Thermo Fisher Scientific’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.